Maven Bio (YC S23) — Live intelligence for biopharma teams
Maven Bio is a live intelligence platform for biopharma teams. It continuously monitors clinical, regulatory, company, and deal developments, identifies what matters to each team's priorities, and delivers signals and updates to keep key documents current.
Maven Bio is a Y Combinator company in the Summer 2023 batch. Its directory entry describes it as: Live intelligence for biopharma teams. The founders listed are Michael Brady (Founder), Arjun Murthy (Founder) (Y Combinator directory entry, July 11, 2023).
Get an email when Maven Bio changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
Maven Bio is a live intelligence platform for biopharma teams. It continuously monitors clinical, regulatory, company, and deal developments, identifies what matters to each team's priorities, and delivers signals and updates to keep key documents current. Its monitoring agent can apply edits automatically, with sources attached and the option to roll back changes.
Maven runs thousands of monitors across company and individual product websites, trade press, health technology assessment bodies, and patient advocacy groups worldwide. Teams use that intelligence to maintain competitive views, asset screens, and recurring briefs, in Maven or through connected AI assistants and custom workflows.
Michael Brady
Founder
Arjun Murthy
Founder
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Maven Bio?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Maven Bio: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Maven Bio covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Maven Bio: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
